Globalisation on pause? How scaleups can navigate today's uncertainty9:30 am - 10:30 am
BGF appoints Daina Spedding to its London investment team
BGF has appointed Daina Spedding as an investor in its London office.
Daina joins from the investment team at Blue Coast Capital, where she sourced and executed investment opportunities in global consumer and digital companies for eight years. Before that she spent five years in PwC’s transaction services team, specialising in company valuations and analysis.
Her role at BGF will cover all aspects of the investment process, from initial meetings with business owners considering funding, to due diligence and actively working alongside portfolio companies after completion.
BGF has invested more than £485m across 80 businesses based in London since it was set up in 2011. Recent investments include fire and security business BB7, talent acquisition consultancy Elements Talent Solutions and filtration equipment manufacturer Amazon Filters.
Commenting on her appointment, Daina said: “BGF has been impressively active in the market, no doubt due to its long-term outlook and the reputation of a fantastic team. I’m delighted to be joining the business here in London at such an exciting time, helping to further build a diverse portfolio and working with some of the UK’s most exciting and ambitious entrepreneurs.”
Grant Paul-Florence, head of BGF’s London office, said: “Daina’s track record of deal sourcing, relationship building with entrepreneurs and advisors, and portfolio management will be a real asset to the team. We’re excited to welcome her to the London office as we continue to expand our offering.”
Business funding news
OSL receives £3.5 million follow-on investment as impressive growth continues
BGF has invested a further £3.5 million into leading counter-drone technologies business Operational Solutions Limited (OSL), taking its total investment…
ViaNautis raises £20 million Series A financing to drive the next generation of genetic nanomedicines
ViaNautis Bio, a ground-breaking nanomedicine company at the forefront of genetic therapies, has completed its Series A funding round, raising…